Henry Schein (HSIC) Gross Margin (2009 - 2026)
Henry Schein (HSIC) recorded quarterly Gross Margin of 31.77% in Q1 2026, up 2.72% quarter-over-quarter from 30.93% in Q4 2025, and up 20.0% on a YoY basis from 26.47% in Q1 2025.
Henry Schein (HSIC) Gross Margin (2009 - 2026) Analysis & Trends
Henry Schein's Gross Margin history runs 18 years deep, the most recent figure standing at 31.77% for Q1 2026.
- In Q1 2026, Gross Margin rose 20.0% year-over-year to 31.77%; the TTM figure through Mar 2026 stood at 31.19% (down 41.0% YoY), while the FY2025 annual figure was 31.14%, down 55.0% from the prior year.
- Gross Margin was 31.77% for Q1 2026 at Henry Schein, up from 30.93% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 32.46% in Q2 2024 to a low of 29.64% in Q4 2022.
- Historically, Gross Margin has averaged 31.14% across 5 years, with a median of 31.29% in 2024.
- The sharpest annual moves came in 2023 and 2025: Gross Margin surged 167 bps in 2023, then slumped 110 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 29.64% in 2022, then gained by 3 bps to 30.63% in 2023, then increased by 2 bps to 31.12% in 2024, then slipped by 1 bps to 30.93% in 2025, then advanced by 3 bps to 31.77% in 2026.
- The last three Gross Margin figures came in at 31.77% (Q1 2026), 30.93% (Q4 2025), and 30.73% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 4.20% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 4.58% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 4.10% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 31.77% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 49.76% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 45.73% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 5.85% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 7.70% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 31.77% |
| Dec 27, 2025 | 30.93% |
| Sep 27, 2025 | 30.73% |
| Jun 28, 2025 | 31.36% |
| Mar 29, 2025 | 31.57% |
| Dec 28, 2024 | 31.12% |
| Sep 28, 2024 | 31.29% |
| Jun 29, 2024 | 32.46% |
| Mar 30, 2024 | 31.90% |
| Dec 30, 2023 | 30.63% |
| Sep 30, 2023 | 31.47% |
| Jul 1, 2023 | 31.45% |
| Apr 1, 2023 | 31.57% |
| Dec 31, 2022 | 29.64% |
| Sep 24, 2022 | 29.80% |
| Jun 25, 2022 | 31.19% |
| Mar 26, 2022 | 30.61% |
| Dec 25, 2021 | 29.42% |
| Sep 25, 2021 | 28.70% |
| Jun 26, 2021 | 30.03% |